Since its formation in 1996, Alta Partners has raised eight venture capital funds, and currently manages $1.5 billion in capital. Historically, the firm invested out of two separate fund families. The Alta California Partners (ACP) funds are dedicated to early-stage investments, while the Alta BioPharma (ABP) funds focus on later-stage private companies and early public companies. ACP IV marked Alta's shift towards a singular focus on life sciences investing.

Alta Partners VIII

Alta Partners VIII, our most recent fund, is the first stage-independent life sciences fund for Alta. AP VIII will target companies across the continuum, from company formation to later-stage companies, both private and public.